Discover hepizovac Solution

How to use

• Suspension for subcutaneous injection
• Should be administered from 2 months of age
• Administer two doses of 4 mL subcutaneously 3 weeks apart

Why to choose Hepizovac?

Unique in prevention

The only vaccine that prevents viremia, effectively limiting virus transmission from infected animals to the vector

Protection from early age

Can be used from 2 months of age

Safety

High safety level, proven in field use

Related videos

Epizootic Haemorrhagic Disease (EHD), a spreading vector-born disease. Jérôme Lafon

Epizootic Hemorrhagic Disease (EHD) is a viral illness that affects ruminants. It is caused by an orbivirus and transmitted by biting midges from the Culicoides family. Since its appearance in France in the autumn of 2023, numerous outbreaks have been reported, underscoring the urgent need for effective prevention measures.

In this video, we explain what EHD is, share real cases reported among Jérôme’s clients, and explore how farmers are preparing for the upcoming epizootic season. We also highlight the support Jérôme offers through his clinic, outline essential prevention strategies, and examine the impact and economic losses caused by this disease.

Epizootic Haemorrhagic Disease (EHD), a spreading vector-born disease. Philippe Gisbert

Epizootic Haemorrhagic Disease (EHD) is an emerging vector-borne disease in Europe that has spread rapidly among cattle since its first detection in 2022. Initially identified in Spain, Sardinia, and Sicily, the disease reached southwestern France in 2023 and now affects a large part of the western region of the country.

In this video, we take a closer look at what EHD is, share key insights gained after a year of dealing with the disease, review current preventive measures, and offer feedback on the efficacy and safety of the EHD vaccine.